Brinker Capital Investments’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.08M Buy
8,587
+1,121
+15% +$141K 0.01% 1157
2025
Q1
$1.02M Buy
7,466
+620
+9% +$84.8K 0.01% 1073
2024
Q4
$1.05M Buy
6,846
+754
+12% +$115K 0.01% 1029
2024
Q3
$1.18M Sell
6,092
-1,237
-17% -$240K 0.01% 957
2024
Q2
$1.7M Buy
7,329
+140
+2% +$32.5K 0.02% 726
2024
Q1
$1.55M Sell
7,189
-1,326
-16% -$286K 0.02% 781
2023
Q4
$2.2M Sell
8,515
-954
-10% -$246K 0.03% 584
2023
Q3
$2.43M Buy
9,469
+316
+3% +$81.2K 0.03% 528
2023
Q2
$10.6M Buy
9,153
+42
+0.5% +$48.7K 0.11% 172
2023
Q1
$2.53M Buy
9,111
+1,136
+14% +$316K 0.03% 501
2022
Q4
$2.21M Sell
7,975
-3,217
-29% -$891K 0.04% 437
2022
Q3
$2.99M Buy
11,192
+777
+7% +$207K 0.06% 305
2022
Q2
$2.12M Buy
10,415
+3,205
+44% +$654K 0.04% 450
2022
Q1
$1.52M Sell
7,210
-2,497
-26% -$526K 0.02% 640
2021
Q4
$2.33M Buy
9,707
+827
+9% +$198K 0.03% 512
2021
Q3
$3.08M Hold
8,880
0.05% 407
2021
Q2
$3.08M Buy
8,880
+409
+5% +$142K 0.04% 462
2021
Q1
$2.37M Sell
8,471
-7,231
-46% -$2.02M 0.04% 461
2020
Q4
$3.85M Buy
15,702
+8,017
+104% +$1.96M 0.06% 393
2020
Q3
$2.18M Buy
+7,685
New +$2.18M 0.04% 444
2020
Q1
Sell
-195
Closed -$58K 348
2019
Q4
$58K Buy
195
+4
+2% +$1.19K ﹤0.01% 411
2019
Q3
$44K Sell
191
-469
-71% -$108K ﹤0.01% 440
2019
Q2
$154K Buy
660
+432
+189% +$101K ﹤0.01% 422
2019
Q1
$54K Buy
228
+214
+1,529% +$50.7K ﹤0.01% 464
2018
Q4
$4K Hold
14
﹤0.01% 562
2018
Q3
$5K Hold
14
﹤0.01% 522
2018
Q2
$4K Buy
+14
New +$4K ﹤0.01% 543
2017
Q3
Sell
-4
Closed -$1K 579
2017
Q2
$1K Buy
+4
New +$1K ﹤0.01% 467
2016
Q4
Sell
-1
Closed 494
2016
Q3
$0 Sell
1
-3,345
-100% ﹤0.01% 499
2016
Q2
$809K Buy
3,346
+1,306
+64% +$316K 0.03% 192
2016
Q1
$531K Buy
2,040
+96
+5% +$25K 0.02% 210
2015
Q4
$596K Buy
1,944
+68
+4% +$20.8K 0.03% 214
2015
Q3
$547K Buy
+1,876
New +$547K 0.02% 219